Both Moderna and Pfizer-BioNTech have asked the agency to approve their vaccines for the youngest children.
Tag: BioNTech SE
-
Pfizer Says Booster Strengthens Immune Response for Children 5 to 11
Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
-
F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Older
People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies are also eligible.
-
Biden Administration Likely to Offer Older Americans Second Booster Shots
Federal officials appear to be coalescing around a plan to offer people 65 and older — and possibly some younger adults — the option of another booster, in case infections surge again soon.
-
Sinovac Booster Gives Elderly Stronger Protection Against Omicron, Study Finds
Given the surge of Omicron cases in Asia, the new research lends urgency to vaccination campaigns in China and Hong Kong.